Twitter Discord

Publications 2026 - Journal papers

More
8 hours 5 minutes ago #20 by christophe.nioche
Publications 2026 - Journal papers was created by christophe.nioche
Articles (20):
  1. LIFEx-texture: Prasanth, Pratheek N.*,a,*; Ravina, Mudalshaa; Ganga, Ranganath T.*,b,*; Raju, Shobhanaa; Kumar, Amitc; Kote, Rutujaa; Reddy, Moulisha; Naik, Vamshi B.a; Krishnan, Saratha; Shukla, Arvind Kumard. Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography metabolic radiomics in predicting response to chemotherapy in patients with non-small cell lung cancer. Nuclear Medicine Communications ():10.1097/MNM.0000000000002127, February 20, 2026. | doi.org/10.1097/MNM.0000000000002127
  2. LIFEx-texture: Spiegel, T.; Rasul, S.; Pötsch, N.; Stiglbauer-Tscholakoff, A.; Kapetas, P.; Nics, L.; Gebhart, P.; Rausch, I.; Bago-Horvath, Z.; Clauser, P.; et al. Uptake Patterns of [18F]Fluoroestradiol PET/MRI in Benign Breast Lesions and Molecular Breast Cancer Subtypes. Cancers 2026, 18, 696.  doi.org/10.3390/cancers18040696
  3. LIFEx-texture: Amrane, K., Cabarrou, B., Le Meur, C. et al. Prognostic value of TMTV and Dmax calculated from 18F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockade. Eur J Nucl Med Mol Imaging (2026).  doi.org/10.1007/s00259-025-07727-9
  4. LIFEx-texture: Dambrain, A., Lacombe, M., Dufour, P.A. et al. Clinical value of artificial intelligence in reducing PET image acquisition time: routine clinical validation using qualitative, quantitative, and radiomic analysis on a cohort of 282 patients undergoing [18F]FDG and [68Ga]Ga-PSMA-11 PET/CT. EJNMMI Phys (2026).  doi.org/10.1186/s40658-026-00835-x
  5. LIFEx-texture: Müller, L.; Gairing, S.J.; Kloeckner, R.; Foerster, F.; Weinmann, A.; Mittler, J.; Stoehr, F.; Emrich, T.; Düber, C.; Galle, P.R.; et al. Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy. Cancers 2022, 14, 3574. doi.org/10.3390/cancers14153574
  6. LIFEx-texture: Erba, P.A., Zanca, R., Sollini, M. et al. Diagnostic value and interpretability of [18F]FDG-PET/CT radiomics in infective endocarditis. EJNMMI Res 16, 33 (2026).  doi.org/10.1186/s13550-025-01366-9
  7. LIFEx-texture: Tang, P., Li, M., Kang, Y., Wu, X. Development of an Individualized CT-based Radiomics Nomogram for Preoperative Differentiation Between Gastric Stromal Tumors and Gastric Leiomyomas. J. Vis. Exp. (228), e69527, doi.org/10.3791/69527 (2026).
  8. LIFEx-texture: Aksu, A., Us, A., Güç, Z.G. et al. Pseudotime-Based derivation of a PET-Based metabolic progression index for prognostic stratification in Extensive-Stage SCLC. Ann Nucl Med (2026). doi.org/10.1007/s12149-026-02162-8
  9. LIFEx-texture: Filippi, L., Bianconi, F., Marongiu, A. et al. SPECT-based radiomics in oncology: current evidence, technical challenges, and future directions. Clin Transl Imaging (2026). doi.org/10.1007/s40336-026-00750-2
  10. LIFEx-texture: Durmaz, Mustafa et al. CT-based radiomics for predicting PD-L1 expression status in non-small cell lung cancer using a hybrid machine learning model. Clinical Imaging, Volume 132, 110742. Cardiothoracic Imaging Volume 132, 110742 April 2026. doi.org/10.1016/j.clinimag.2026.110742
  11. LIFEx-texture: Tomoki Matsushita, Takayoshi Shinya, Toshihiko Nishisho, Koichi Sairyo, Yoshimi Bando, Hisanori Uehara and Masafumi Harada. The Diagnostic Ability of Texture Analysis in MR Imaging for Neurogenic Tumors. The Journal of Medical Investigation Vol. 72 2025. doi.org/10.2152/jmi.72.367
  12. LIFEx-MTV: Bosque, J.J., Molina-García, D., Pérez-Beteta, J. et al. Complementary prognostic value of hotspot-to-centroid distance (NHOCpeak) to SUVpeak in high-grade glioma. Ann Nucl Med (2026). doi.org/10.1007/s12149-025-02138-0
  13. LIFEx-MTV: Mirshahvalad, S.A., Kohan, A., Kulanthaivelu, R. et al. Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy. Sci Rep 15, 39540 (2025).  doi.org/10.1038/s41598-025-23159-9
  14. LIFEx-MTV: Dondi, F., Bertoli, M., Bellini, P. et al. Relationship between epicardial adipose tissue and coronary function evaluated with [13 N]NH3 PET/CT.. Int J Cardiovasc Imaging (2026).  doi.org/10.1007/s10554-026-03612-0
  15. LIFEx-texture: Brunese, M.C., Clemente, A., De Chiara, M. et al. Radiomics of portal-phase ring enhancement: a novel imaging biomarker for bevacizumab response associated with overall survival rates. It might help with surgical decision-making in colorectal liver metastases?. Updates Surg (2026).  doi.org/10.1007/s13304-025-02501-w
  16. LIFEx-texture: S. Hai et al., "Multimodal Radiomic Profiling Can Distinguish AT1- and AT2- Cell of Origin Lung Adenocarcinoma Models," 2025 21st International Symposium on Biomedical Image Processing and Analysis (SIPAIM), Pasto, Colombia, 2025, pp. 1-4,  doi.org/10.1109/SIPAIM67325.2025.11283389
  17. LIFEx-texture: Feng J, Yang Y, Liu S, Qin A, Ye J, Jiang Y. [Predictive value of a multimodal radiomics model for central lymph node metastasis in clinically node-negative papillary thyroid microcarcinoma based on machine learning]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2026 Jan 21:1-10. Chinese. http://doi.org10.3724/zdxbyxb-2025-0648. Epub ahead of print. PMID: 41558987.
  18. LIFEx-texture: Xu, Q., Chen, Y., Song, J. et al. Prognostic value of baseline [68Ga]Ga‑DOTA‑NOC PET/CT in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging (2026).  doi.org/10.1007/s00259-025-07745-7
  19. LIFEx-texture: Crombé, A., Sitruk, L.A., Masson-Grehaigne, C. et al. Single and multi-site CT-based radiogenomics analysis of metastatic lung adenocarcinoma and correlations with outcome. Eur Radiol (2026).  doi.org/10.1007/s00330-025-12292-8
  20. LIFEx-main: Yuqi Zhao, Ying Chen, Furui Duan, Xixi Li, Yu Zhao, Funing Yang, Ping Li. Non-invasive Prediction of CYP11B2-Defined Subtypes in Primary Aldosteronism Using 18F-Pentixafor PET/CT and Machine Learning. Academic Radiology, 2026, ISSN 1076-6332, doi.org/10.1016/j.acra.2025.12.026

Please Log in or Create an account to join the conversation.

Time to create page: 0.609 seconds